SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

ALC Alcidion Group Limited

Healthcare · Health Information Services · website · 141 employees
$0.10
52wk 0.08 – 0.14
Overall
44.8
Value
37.7
Growth
56.1
Health
61.0
Quality
16.0
Momentum
46.2
Dividend
—
Price
About Alcidion Group Limited

Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR) events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company's platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions. In addition, the company offers Smartpage, a smartphone and web-based system for hospital communication and task management; and product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.

Price analytics

Returns

1 day -4.8%
1 week -4.8%
1 month 2.6%
3 months 0.0%
6 months 0.0%
1 year 7.5%
3 years -9.1%

Risk

Volatility (1y ann.) 60.1%
Beta vs ASX 200 0.54
Sharpe (1y) 0.35
VaR 95% (1-day) -4.8%
Max drawdown (1y) -38.6%
Off 1-year high -28.6%

Technicals

RSI(14) 50
vs 50DMA 3.8%
vs 200DMA -2.1%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 37.7
Trailing P/E
—
Forward P/E
18
PEG ratio
—
EV / EBITDA
0
Price / Book
91
Price / Sales
80
Growth 56.1
Revenue growth (1y)
65
Revenue CAGR (3y)
47
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 61.0
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
0
Current ratio
24
Debt / Equity
100
Quality (Profitability & Cash Flow) 16.0
Return on equity
13
Return on assets
13
Operating margin
9
Net margin
30
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 46.2
6-month return vs ASX 200
46
Price vs 200-day average
43
Price vs 50-day average
69
Position in 52-week range
27

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$134.98M
P/E (trailing)
—
P/E (forward)
30.12
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
1.08
EV / EBITDA
21.46
Price / Book
1.47
ROE
2.6%
Operating margin
2.2%
Net margin
4.4%
Total cash
$20.64M
Total debt
$814,000
Current ratio
1.22
Debt / Equity
0.01
Free cash flow
$7.20M
Avg volume
1.04M
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$41.81M
  • Gross profit$31.62M
  • Operating income-$7.52M
  • Net income$2.29M
  • Diluted EPS—
  • Free cash flow$6.62M
  • Net debt-$19.83M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4